“We expect to analyse patient safety data more quickly and detect trends”

With the introduction of SafeTrack tool, Bayer Zydus Pharma takes a step further in enhancing patient security. The tool allows patients, consumers, family, friends, caregivers and healthcare professionals to report side effects quickly. The company believes that good information is crucial for effective treatment. Manoj Saxena, Managing Director, Bayer Zydus Pharma discusses more about the web-based tool, SafeTrack, with Usha Sharma

Recently, Bayer has introduced the adverse event reporting tool for the public. Tell us the objective behind the launch?

At Bayer, we strive to learn from patients’ first-hand experience with our treatments. Any adverse event or reaction, or special circumstance, whether listed or not in the product information, should always be reported to the pharmaceutical company or to the national health authority according to the specific country’s requirement. This helps us to detect potential safety issues early and allows quick action to be taken, if needed, to protect the safety of both current and future patients. SafeTrack is part of our commitment to protecting patients. The web based tool makes reporting side effects quick and easy for patients, consumers, family, friends or caregivers and healthcare professionals.

How do you ensure that Pharmacovigilance creates a steady stream of information?